Legume Consumption and Blood Pressure Control in Individuals with Type 2 Diabetes and Hypertension: Cross-Sectional Findings from the TOSCA.IT Study.
TOSCA.IT study
hypertension
legume consumption
pulses
type 2 diabetes
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
26 Jun 2023
26 Jun 2023
Historique:
received:
01
06
2023
revised:
19
06
2023
accepted:
21
06
2023
medline:
17
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
Our aims were to evaluate the relationship of habitual legume consumption with blood pressure (BP) control in a large cohort of people with T2D and hypertension, and to investigate whether specific nutritional components of legumes or other foods may contribute to regulate BP levels. We studied 1897 participants with T2D and hypertension. Dietary habits were assessed through a validated food frequency questionnaire. Sex-specific quartiles of legume consumption were created. Higher legume consumption was associated with a lower intake of energy, carbohydrates, glycaemic load, alcohol, and sodium, and a significantly greater intake of proteins, fat, monounsaturated, polyunsaturated, fibre, potassium, and polyphenols. Significantly lower systolic and diastolic BP values were observed in the highest vs. lowest quartile of legume consumption (132.9 ± 6.7 vs. 137.3 ± 7.0 mmHg, In people with T2D and hypertension, three servings of legumes per week are associated with significantly better BP control. This gives further support to current dietary guidelines in recommending the frequent consumption of legumes, as a "ready-to-use" dietary strategy to achieve optimal BP control.
Sections du résumé
BACKGROUND
BACKGROUND
Our aims were to evaluate the relationship of habitual legume consumption with blood pressure (BP) control in a large cohort of people with T2D and hypertension, and to investigate whether specific nutritional components of legumes or other foods may contribute to regulate BP levels.
METHODS
METHODS
We studied 1897 participants with T2D and hypertension. Dietary habits were assessed through a validated food frequency questionnaire. Sex-specific quartiles of legume consumption were created.
RESULTS
RESULTS
Higher legume consumption was associated with a lower intake of energy, carbohydrates, glycaemic load, alcohol, and sodium, and a significantly greater intake of proteins, fat, monounsaturated, polyunsaturated, fibre, potassium, and polyphenols. Significantly lower systolic and diastolic BP values were observed in the highest vs. lowest quartile of legume consumption (132.9 ± 6.7 vs. 137.3 ± 7.0 mmHg,
CONCLUSIONS
CONCLUSIONS
In people with T2D and hypertension, three servings of legumes per week are associated with significantly better BP control. This gives further support to current dietary guidelines in recommending the frequent consumption of legumes, as a "ready-to-use" dietary strategy to achieve optimal BP control.
Identifiants
pubmed: 37447221
pii: nu15132895
doi: 10.3390/nu15132895
pmc: PMC10343530
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Italian Medicines Agency
ID : FARM6T9CET
Références
Adv Nutr. 2019 Nov 1;10(Suppl_4):S308-S319
pubmed: 31728500
Int J Epidemiol. 1997;26 Suppl 1:S152-60
pubmed: 9126543
Diabetes Care. 2022 Jan 1;45(Suppl 1):S113-S124
pubmed: 34964843
Adv Nutr. 2017 Nov 15;8(6):793-803
pubmed: 29141965
Nutrients. 2018 Nov 07;10(11):
pubmed: 30405063
Int J Mol Sci. 2017 Nov 04;18(11):
pubmed: 29113066
Am J Hypertens. 2014 Jan;27(1):56-64
pubmed: 24014659
Eur J Clin Nutr. 2015 May;69(5):592-7
pubmed: 25351652
Clin Nutr. 2021 May;40(5):3191-3200
pubmed: 33581952
J Cardiometab Syndr. 2006 Spring;1(2):95-101
pubmed: 17679829
Hypertension. 2022 May;79(5):1017-1027
pubmed: 35264000
Crit Rev Food Sci Nutr. 2021;61(12):2003-2021
pubmed: 32478570
BMJ. 1998 Sep 12;317(7160):703-13
pubmed: 9732337
Database (Oxford). 2013 Oct 07;2013:bat070
pubmed: 24103452
Database (Oxford). 2010;2010:bap024
pubmed: 20428313
Lancet. 2014 Jun 7;383(9933):1999-2007
pubmed: 24910231
Diabetes Care. 1993 Feb;16(2):434-44
pubmed: 8432214
Arch Intern Med. 2012 Nov 26;172(21):1653-60
pubmed: 23089999
Hypertension. 2022 Jan;79(1):293-301
pubmed: 34775787
Diabetes Care. 1998 Apr;21(4):539-45
pubmed: 9571339
Am Fam Physician. 2021 Jun 15;103(12):763-765
pubmed: 34128614
Lancet. 1981 Jan 3;1(8210):1-5
pubmed: 6109047
Tumori. 2003 Nov-Dec;89(6):594-607
pubmed: 14870824
Kidney Int. 2012 Feb;81(3):300-6
pubmed: 22012132
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
Can J Cardiol. 2015 May;31(5):569-71
pubmed: 25795106
N Engl J Med. 1998 Jul 23;339(4):229-34
pubmed: 9673301
Nutr Metab Cardiovasc Dis. 2012 Nov;22(11):997-1006
pubmed: 23063367
Am J Clin Nutr. 2006 Apr;83(4):760-6
pubmed: 16600925
Arch Intern Med. 1996 Mar 25;156(6):622-7
pubmed: 8629873
BMJ. 2000 Aug 12;321(7258):412-9
pubmed: 10938049
J Am Diet Assoc. 1999 Aug;99(8 Suppl):S12-8
pubmed: 10450289
N Engl J Med. 2001 Jan 4;344(1):3-10
pubmed: 11136953
Curr Opin Cardiol. 2018 Jul;33(4):388-393
pubmed: 29771736
Lancet Diabetes Endocrinol. 2017 Nov;5(11):887-897
pubmed: 28917544
Diabetes Care. 2006 Oct;29(10):2313-5
pubmed: 17003313
Lancet. 2019 Feb 2;393(10170):447-492
pubmed: 30660336
J Am Coll Nutr. 2008 Oct;27(5):569-76
pubmed: 18845707
Nutrients. 2022 Aug 16;14(16):
pubmed: 36014869
Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2381-2388
pubmed: 29063193